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Abstract
Barth syndrome (BTHS) is an X-linked condition characterized by altered car-
diolipin metabolism and cardioskeletal myopathy. We sought to compare car-
diac and skeletal muscle bioenergetics in children, adolescents, and young
adults with BTHS and unaffected controls and examine their relationships
with cardiac function and exercise capacity. Children/adolescents and young
adults with BTHS (n = 20) and children/adolescent and young adult control
participants (n = 23, total n = 43) underwent 31P magnetic resonance spec-
troscopy (31P-MRS) of the lower extremity (calf) and heart for estimation of
skeletal muscle and cardiac bioenergetics. Peak exercise testing (VO2peak) and
resting echocardiography were also performed on all participants. Cardiac
PCr/ATP ratio was significantly lower in children/adolescents (BTHS:
1.5  0.2 vs. Control: 2.0  0.3, P < 0.01) and adults (BTHS: 1.9  0.2 vs.
Control: 2.3  0.2, P < 0.01) with BTHS compared to Control groups. Adults
(BTHS: 76.4  31.6 vs. Control: 35.0  7.4 sec, P < 0.01) and children/ado-
lescents (BTHS: 71.5  21.3 vs. Control: 31.4  7.4 sec, P < 0.01) with BTHS
had significantly longer calf PCr recovery (sPCr) postexercise compared to
controls. Maximal calf ATP production through oxidative phosphorylation
(Qmax-lin) was significantly lower in children/adolescents (BTHS: 0.5  0.1
vs. Control: 1.1  0.3 mmol/L per sec, P < 0.01) and adults (BTHS:
0.5  0.2 vs. Control: 1.0  0.2 mmol/L sec, P < 0.01) with BTHS compared
to controls. Blunted cardiac and skeletal muscle bioenergetics were associated
with lower VO2peak but not resting cardiac function. Cardiac and skeletal mus-
cle bioenergetics are impaired and appear to contribute to exercise intolerance
in BTHS.
Introduction
Barth syndrome (BTHS) is a X-linked disorder resulting
from mutations in the gene encoding for tafazzin (TAZ)
(Bione et al. 1996) and is characterized by heart failure,
exercise intolerance, fatigue, and premature mortality
(Barth et al. 1983). TAZ, a phospholipid-lysophospholipid
transacylase, remodels monolysocardiolipin to tetrali-
noleoyl-cardiolipin which provides inner membrane sta-
bility necessary for ATP production by the electron
transport chain (Zhang et al. 2002). Mutations in TAZ
result in an increase in monolysocardiolipin and reduc-
tion in tetralinoleoyl-cardiolipin (Schlame et al. 2003),
smaller and fragmented mitochondria (Wang et al. 2014),
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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disruptions in mitochondrial supercomplexes (Xu et al.
2016), instability in the mitochondrial inner membrane
(Zhang et al. 2002), and markedly reduced respiratory
capacity (Wang et al. 2014).
Our group previously demonstrated severe impairments
in whole-body oxygen consumption during peak exercise
that was due to a combination of cardiac and skeletal
muscle impairments (Spencer et al. 2011). Furthermore,
using near-infrared spectroscopy we found that skeletal
muscle (lateral quadriceps) oxygen extraction was signifi-
cantly blunted during exercise in children, adolescents,
and young adults with BTHS suggesting impaired mito-
chondrial energetics in these individuals (Spencer et al.
2011). Wang et al. (2014). recently found blunted mito-
chondrial energetics and reduced contractile function in
cardiomyocytes derived from inducible pluripotent stem
cells made from human BTHS fibroblasts; however, the
effects of BTHS on whole tissue cardiac and skeletal mus-
cle bioenergetics and their relationship with cardiac and
skeletal muscle function in humans, in vivo, remain
unknown.
The use of phosphorus magnetic resonance spec-
troscopy (31P-MRS) to noninvasively measure skeletal
muscle (Kemp et al. 2015; Sapega et al. 1993) and cardiac
bioenergetics (Hudsmith and Neubauer 2009; Ingwall
et al. 1985) is well-established (Chance et al. 1981). Mea-
surement of phosphocreatine (PCr) recovery following
muscular exercise provides an accurate estimate of oxida-
tive metabolism (Meyer 1988) as PCr intricately links
mitochondrial and myofibrillar ATP production from
oxidative phosphorylation (Altschuld and Brierley 1977;
Meyer et al. 1984). Reduced PCr/ATP ratio is characteris-
tic of failing myocardium (Conway et al. 1991) and rep-
resents a reduced capacity or reserve to provide ATP to
the working heart, especially during stressed conditions
(Nascimben et al. 1996; Smith et al. 2006). Skeletal mus-
cle and cardiac bioenergetics might be useful biomarkers
or outcome measures for prospective studies and clinical
trials in BTHS as individuals with BTHS frequently have
normal resting cardiac function without a predictable nat-
ural history (Spencer et al. 2006; Thompson et al. 2016).
In addition, cardiac bioenergetics have been shown to
respond favorably to interventions (Spoladore et al. 2013)
and to be useful predictors of cardiovascular and all-cause
mortality in patients with non-BTHS heart failure (Neu-
bauer et al. 1997).
Therefore, the primary objective of this study was to
compare cardiac and skeletal muscle bioenergetics in chil-
dren, adolescents, and young adults with BTHS to unaf-
fected age and activity level matched controls. The
secondary objective was to examine the relationships
between cardiac and skeletal muscle bioenergetics, cardiac
function, and exercise capacity. We hypothesized that
individuals with BTHS would have marked reductions in
cardiac and skeletal muscle bioenergetics and that these
would be associated with lower cardiac function and exer-
cise capacity.
Materials and Methods
Forty-three (total n = 43) participants: 30 children/ado-
lescents (BTHS n = 14, Control n = 16) and 13 adults
(BTHS n = 6, Control n = 7) between 18 and 36 years of
age were included (Table 1). Participants with BTHS were
recruited through the Barth Syndrome Registry located at
the University of Florida and controls were recruited
through nonaffected siblings and local recruitment from
the Greater St. Louis community. Control participants
were considered sedentary, defined as currently participat-
ing in structured exercise ≤29 per week. All participants
completed skeletal muscle 31P-MRS, however, due to
technical difficulties two children and one adult were not
able to complete the cardiac 31P-MRS. Studies were
approved by the Human Studies Committee at Washing-
ton University in St. Louis and all participants provided
assent and all participants and/or parents provided writ-
ten informed consent.
Cardiac bioenergetics
Cardiac and skeletal muscle experiments were performed
by using a Siemens 3T magnet equipped with broadband
capabilities (Siemens Medical Systems, Erlangen, Ger-
many) using a home built 31P transmit-receive RF coil.
Cardiac 31P-MRS was performed with the participant in
the supine position using 1D-ISIS localization, as previ-
ously described (Bashir and Gropler 2014). Briefly, partic-
ipants were positioned with their heart at the center of
the magnet, and the 31P surface coil was positioned on
the chest with the center of the coil just below the mitral
valve of the heart using proton scout images. A small
fiducial marker placed at the center of the RF coil to
adjust the positioning of the coil relative to the heart. A
non-localized 31P spectrum was then acquired and RF
transmit frequency was centered on the PCr resonance.
Data were acquired following 2.56 msec adiabatic half
passage pulse radiofrequency pulses applied at 6 s inter-
vals and with a spectral width of 2 kHz and 64 averages
per spectrum.
Spectra were processed offline using the jMRUI (Java-
Based Magnetic Resonance User Interface) software (Nar-
essi et al. 2001). Spectra were fitted in time domain by
using a nonlinear least-squares algorithm (AMARES)
(Vanhamme et al. 1997). ATP, PCr, 2,3-diphosphoglyce-
rate (DPG), and phosphodiester (PDE) signals were fitted
to Lorentzian line shapes. The three ATP peaks were
2017 | Vol. 5 | Iss. 3 | e13130
Page 2
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society.
Impaired Energetics in Barth Syndrome A. Bashir et al.
fitted as two doublets and one triplet, with equal ampli-
tudes and line widths and prior knowledge for the J-cou-
pling constant. After fitting, the c-ATP peak area was
corrected for blood contamination according to the
amplitude of the 2,3-diphosphoglycerate (2,3-DPG) peak
as described previously. PCr/ATP ratio was calculated and
corrected for partial saturation (El-Sharkawy et al. 2009).
Skeletal muscle bioenergetics
Calf muscle bioenergetic function was determined from
the recovery of PCr after plantar flexion exercise. Single-
leg plantar flexion exercise was performed using a cus-
tom-built ergometer designed to fit in the bore of the
MRI scanner. During the exercise protocols, participants
laid supine on the ergometer with the legs extended and
strapped to the ergometer base in order to reduce bulk
motion. A 9 cm 31P RF coil was placed under the calf
and held in place with straps. Exercise consisted of 0–22°
plantarflexion exercise against a force adjusted to 40% of
maximal voluntary contraction (MVC) using a pressur-
ized pneumatic cylinder. To ensure that all participants
were capable of performing plantar flexions inside the
scanner they were asked to perform (10 or less) plantar
flexion extensions while in the scanner. Contraction-
relaxation cycles were gated to the magnetic resonance
acquisition on the basis of an audible signal with one
contraction every 2 sec. After the initial familiarization
period the participants were given a 10 min rest before
the start of the exercise-recovery 31P-MRS experiment.
During the exercise, each participant performed 30 plan-
tar flexions at a cadence of 1 plantar flexion exercise every
2 sec acoustically guided by gradient noise from the scan-
ner. Exercise performance was monitored and recorded
using Digital Gauge and Transmitter (Ashcroft Industries,
Stratford, CT) and USB-6009 Data Acquisition unit
(National Instruments, Austin, TX).
31P-MRS data were also acquired at rest with repetition
time of 20 sec and 2 sec to correct for partial saturation.
The exercise protocol was then commenced and data were
acquired during and for 8 min after the end of the exer-
cise protocol. Pulse parameters were as follows: 2.56 msec
adiabatic half passage pulse, 2 sec repetition time 1024
data points, 2.5 kHz spectral width.
Relative ratio of the resonances area was determined
using jMRUI software as described above. Absolute con-
centrations of 31P metabolites were calculated assuming
that resting [ATP] is 8.2 mmol/L (Kemp et al. 2007).
Intramuscular pH was calculated from the chemical shift
difference between PCr and Pi resonances in parts per
million using the following relationship (Taylor et al.
1983)
Table 1. Participant demographics, peak exercise testing, and echocardiography.
Control (n = 16) BTHS (n = 14) P -value Control (n = 7) BTHS (n = 6) P -value
Age (years) 12  3 13  3 0.36 23  5 27  4 0.10
Height (cm) 154.5  17.7 143.8  14.2 0.08 175.7  4.7 178.4  6.7 0.39
Weight (kg) 47.3  18.6 34.9  12.4 0.04 84.5  14.4 68.0  12.6 0.02
FFM (kg) 38.9  15.3 24.3  6.7 0.003 65.7  8.4 42.2  7.2 <0.001
FFM (%) 83  7 68  13 <0.001 79  8 64  11 0.01
FM (kg) 8.0  5.7 12.8  10.2 0.12 18.5  9.3 25.3  9.8 0.17
FM (%) 17  7 32  13 <0.001 21  8 36  11 0.01
Resting HR (bpm) 83  7 85  11 0.58 75  19 74  16 0.43
Resting SBP (mmHg) 106  12 101  12 0.28 137  6 104  9 <0.001
Resting DBP (mmHg) 65  10 67  9 0.58 84  9 65  10 0.17
Exercise variables
VO2peak (mL/kg/min) 36.1  7.7 13.7  3.2 <0.001 35.7  5.9 12.3  3.5 <0.001
Peak watts 143  70 39  10 <0.001 239  51 61  11 <0.001
Peak RER 1.1  0.1 1.3  0.2 0.002 1.2  0.1 1.5  0.2 <0.001
Peak HR 184  11 158  22 <0.001 186  15 159  11 0.001
Peak SBP (mmHg) 144  19 116  16 <0.001 202  24 137  16 <0.001
Peak DBP (mmHg) 70  11 74  16 0.47 88  11 84  11 0.70
Echocardiography
LVM (g) 94.6  30.1 74.6  28.6 0.13 149.7  37.8 127.2  25.6 0.29
Ejection fraction (%) 67  4 63  5 0.02 64  5 57  15 0.18
Fractional shortening (%) 40  6 34  11 0.08 36  6 30  8 0.05
Global strain (%) 21  3 20  2 0.25 18  2 15  3 0.05
Values are means  SD.
FFM, fat-free mass; FM, fat mass; VO2peak, volume of oxygen consumption during peak; LVM, left ventricular mass.
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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pH ¼ 6:75þ logr 3:27
5:96 r
ADP concentration was calculated from [PCr] and pH
using the creatine kinase equilibrium constant
(Keq = 1.66 9 10
9 M1) and assuming that total creatine
[PCr+Cr] is 42.5 mmol/L (Kemp et al. 2001,2007).
½ADP ¼ ½ATP½Cr½PCr½HþKeq
Oxidative capacity was determined from recovery of
PCr after exercise. Postexercise recovery of PCr was fitted
to a single exponential curve PCrðtÞ ¼ DPCr
ð1 et=sPCrÞ þ PCrend where PCrend is the concentration
of PCr at the end of exercise and DPCr is the PCr con-
sumed during exercise (resting [PCr] – PCrend). The ini-
tial rate of PCr recovery (ViPCr) was calculated by
ViPCr ¼ DPCrsPCr
The maximum oxidative capacity was calculated
according Michaelis–Menten kinetics with Km = 30 lmol/
L and taking into account the ADP concentration at the
end of exercise [ADP]end and the initial rate of PCr
recovery (ViPCr) (Chance et al. 1985; Kemp and Radda
1994; Layec et al. 2011)
QmaxADP ¼ ViPCr 1þ
Km
½ADPend
 
Maximal oxidative flux was also calculated according to
the linear model (Meyer 1988)
Qmaxlin ¼
½PCr
sPCr
Rate of oxidative mitochondrial ATP synthesis was
based on the hyperbolic relationship between the
oxidative ATP synthesis rate and the free cytosolic ADP
concentration
ATPox ¼ QmaxADP
1þ Km=½ADP
This model assumes that the oxygen delivery to mito-
chondria is not limited which is expected due to the
nature of the exercise protocol (Lanza et al. 2005; Layec
et al. 2011).
Body composition
Fat mass (kg and %) and fat-free mass (kg and %) in all
participants were determined through air-displacement
plethymosgraphy (Bod Pod, Life Measurements Inc., Con-
cord, CA).
Echocardiography
All participants underwent conventional two-dimensional
(2-D) and pulsed-wave Doppler, (General Electric Vivid
E9; Waukesha, WI). Left ventricular (LV) mass was deter-
mined by 2-D echocardiography according to recommen-
dations of the American Society of Echocardiography
(Lang et al. 2005). LV end-diastolic and end-systolic vol-
umes were determined using the method of disks and LV
ejection fraction was calculated. LV end-diastolic and
end-systolic dimensions (LVED and LVES) were mea-
sured in the parasternal long-axis view. Fractional short-
ening was calculated as (LVED-LVES)/LVED. 2D speckle
tracking echocardiographic-derived peak systolic strain
was determined from the apical four-chamber, two-
chamber, and apical long-axis views and calculated as the
average of the basal, mid- and apical segments of all
walls.
Graded exercise testing
All participants performed a graded exercise test on an
electronically braked recumbent cycle ergometer (Lode
Corvial, The Netherlands). Work rate on the cycle
ergometer started at 10 watts (W) and increased 10 W/
min for all BTHS and for unaffected child controls and
started at 20 W and increased 20 W/min for adolescent
and young adult controls until volitional exhaustion. 12-
lead ECG, blood pressure, and volume of oxygen (VO2)
consumption, carbon dioxide (VCO2) production, and
ventilation (ParvoMedics TrueOne, Sandy, UT) were con-
tinuously measured. Exercise testing was considered peak
with attainment of ≥85% predicted peak heart rate (220-
age) and/or RER ≥ 1.10 according to the (American Col-
lege of Sports Medicine (2000)).
Statistical analysis
Results are presented as mean  standard deviation. Stu-
dent’s unpaired t-tests were used to compare the variables
between BTHS and controls. The relationships between
variables were analyzed by the Pearson correlation coeffi-
cient as data were normally distributed. Statistical signifi-
cance was accepted at P < 0.05
Results
Demographics
Participant demographics are provided in Table 1. There
was one African American adult participant with BTHS,
one African American adult control, two Asian adult con-
trols, and the remaining participants were Caucasian.
2017 | Vol. 5 | Iss. 3 | e13130
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Participants with BTHS were currently taking: beta-block-
ers (52%), ACE inhibitors (39%), cardiac glycosides
(35%), gram colony stimulating factor (30%), antidepres-
sants (17%), and supplemental amino acids (39%). Age
and height were not different between groups. Weights in
children/adolescents and adults with BTHS were signifi-
cantly lower than controls. Absolute fat-free mass (kg)
and fat-free mass expressed as % of total mass in chil-
dren/adolescents and adults with BTHS were significantly
lower than controls. Absolute fat mass was not different
between groups, however, % fat mass, was higher in both
children/adolescents and adults with BTHS compared to
control groups.
Peak exercise testing
VO2peak and peak cycle ergometer resistance (watts) were
significantly lower in children/adolescents and adults with
BTHS compared to control groups. Peak respiratory
exchange ratio was higher in BTHS versus controls and
peak heart rate was lower in both children/adolescents
and adults with BTHS compared to control groups (all
Table 1).
Echocardiography
Ejection fraction and fractional shortening were lower in
children/adolescents with BTHS versus controls. Frac-
tional shortening was lower in adults with BTHS versus
controls but ejection fraction was not different between
groups. Global strain was lower in adults with BTHS ver-
sus controls, however, strain was not different between
the two groups of children/adolescents (all Table 1).
Cardiac bioenergetics
A sample reference image of the heart and location of sat-
uration band to eliminate the signal from the chest mus-
cles is shown in Figure 1A. A typical example of cardiac
31P-MR spectra from a unaffected control participant
(Fig. 1B) and a participant with BTHS (Fig. 1C) with
reduced PCr amplitude is provided in Figure 1. Cardiac
PCr/ATP ratio was significantly lower in children/adoles-
cents and adults with BTHS compared to control groups
(Table 2).
Skeletal muscle bioenergetics
Resting
At rest, pH was not different between the two groups
in both children/adolescents and adults (Table 2).
[PCr], [PCr]/[Pi] ratio, and [PDE] were significantly
higher in children/adolescents with BTHS versus con-
trols and [Pi] and [ADP] tended to be lower in both
children/adolescents and adults with BTHS as compared
to controls. [PCr] tended to be lower and [PCr]/[Pi]
ratio tended to be higher in adults with BTHS versus
controls.
Exercise recovery
A typical spectrum recorded at rest from calf muscle is
displayed in Figure 2A and MR spectra that was continu-
ously recorded during the standardized rest-exercise-
recovery protocol (Fig. 2B). As expected, intramuscular
pH became briefly alkaline during exercise, however, the
Figure 1. Reference images of the heart. Location of saturation band and approximate sensitive region of the RF coil is also shown (A)
Spectrum from a healthy control (B) and a participant with Barth syndrome (C) detailing the peaks of PCr, ATP, PDE, and 2,3 DPG. PCr
resonance amplitude is reduced in spectrum from Barth participant with similar ATP amplitudes. The red dashed lines provide a visual cue of
changes in PCr and ATP peaks. b-ATP resonance in the spectra is diminished due to the bandwidth limitations of the adiabatic RF pulse. DPG,
2,3-diphosphoglycerate; PDE, phosphodiester.
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end-exercise pH was similar to baseline. PCr decreased
during exercise and increased rapidly after cessation of
exercise and followed a mono-exponential time course.
ATP concentration, determined from the c-peak, did not
differ across rest, exercise, or recovery for both protocols.
The calculated ADP concentration increased above
baseline during exercise in both groups and remained sig-
nificantly higher at end-exercise in children with BTHS
(data not shown). Adults and children/adolescents with
BTHS had significantly longer sPCr compared to controls.
Initial rate of PCr recovery (Vi) was significantly lower in
children/adolescents and adults with BTHS versus
Table 2. Resting cardiac and skeletal muscle bioenergetics.
Children Adults
Skeletal Muscle Control (n = 16) BTHS (n = 14) P -value Control (n = 7) BTHS (n = 6) P -value
pH 7.0  0.0 7.1  0.1 0.45 7.0  0.0 7.0  0.0 0.48
[PCr] (mmol/L) 31.3  1.9 35.8  1.8 <0.01 33.3  2.5 35.8  2.5 0.11
[Pi] (mmol/L) 3.0  0.7 2.3  1.2 0.06 2.8  0.7 2.0  0.8 0.08
[PCr]/[Pi] 11.0  3.5 18.7  7.5 <0.01 13.2  5.2 22.1  11.9 0.10
[PDE] (mmol/L) 1.7  0.7 2.6  0.9 0.01 2.4  0.8 2.9  0.7 0.35
[ADP]lmol/L 19.2  4.3 10.6  3.4 <0.01 14.8  5.6 9.7  4.1 0.09
Cardiac
[PCr]/[ATP] 2.0  0.2 1.5  0.2 <0.01 2.3  0.2 1.9  0.2 <0.01
Values are means  SD.
PCr, phosphocreatine concentration; Pi, inorganic phosphate concentration; PDE, phosphodiesterase concentration; ADP, adenosine diphos-
phate concentration; ATP, adenosine triphosphate concentration.
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Figure 2. Typical postexercise PCr recovery data. PCr amplitude (normalized to resting condition) for all participants (A) Adults, (B) Children/
Adolescents). Error bars represent standard error. Representative PCr recovery data from adults (C) and children/adolescents (D) showing
example of signal exponential fit.
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controls. Maximal ATP production rates through oxida-
tive phosphorylation estimated by Qmax-lin and Qmax-ADP
and ATPox was significantly lower in children/adolescents
and adults with BTHS versus control groups (Table 3).
There were no differences in skeletal muscle MRS exercise
variables between adults versus children/adolescents in
with BTHS or in Controls.
Relationships between cardiac and muscle
bioenergetics, cardiac function, and exercise
capacity
Examining both sets of participants with BTHS and con-
trols (n = 43), 31P-MRS markers of mitochondrial func-
tion (sPCr (r = 0.72), Vi (r = 0.46), Qmax-lin (r = 0.69),
Qmax-ADP (r = 0.46), all P < 0.01) revealed significant cor-
relations with VO2peak. Cardiac PCr/ATP was also associ-
ated with VO2peak (r = 0.60, P < 0.001) but was not
associated with resting cardiac function (ejection fraction,
fractional shortening, global strain). When examining
participants with BTHS only (n = 20), sPCr (r = 0.51,
P = 0.02) was related to VO2peak and Qmax-lin (r = 0.41,
P = 0.07) tended toward being related to VO2peak. Car-
diac PCr/ATP was not associated with VO2peak or any
measurement of cardiac function at rest.
Discussion
The principal and novel findings of this study were that
skeletal muscle and cardiac bioenergetics, as determined
from postexercise PCr recovery kinetics using 31P-MRS,
were impaired in both children/adolescents and young
adults with BTHS when compared to unaffected, age-
matched, sedentary controls. A secondary novel finding
was that cardiac and skeletal muscle bioenergetic
impairments were associated with exercise intolerance in
this cohort. Mitochondrial function in tissues such as
myocardium and skeletal muscle is closely integrated
with physiological demands below the anaerobic thresh-
old (Kemp et al. 2015; Wasserman 1987). In BTHS,
in vitro mitochondrial respiration has been shown to
be impaired in inducible pluripotent stem cell derived
human cardiomyocytes (Wang et al. 2014); our data
extend this finding by demonstrating altered in vivo
mitochondrial function in humans with BTHS. Possible
mechanisms for BTHS-associated mitochondrial dysfunc-
tion include mitochondrial supercomplex destabilization
(Gonzalvez et al. 2013), higher degradation and reduced
levels of mitochondrial cardiolipin (Xu et al. 2016),
abnormal mitochondrial morphology (Barth et al. 1983;
Bissler et al. 2002), excessive production of reactive
Figure 3. Scatterplots of VO2peak and (A) sPCR, (B) Vi, C) Qmax-lin, and (D) Qmax-ADP during 60-sec exercise.
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oxygen species (Wang et al. 2014), and/or defects in
ATP synthase activity (Wang et al. 2014). In this study,
skeletal muscle bioenergetics were not different between
adults and children/adolescents in either BTHS or unaf-
fected controls. This appears to be in contrast to stud-
ies in healthy children and adults as children were
found to rely more on oxidative metabolism during
exercise than adults (Ratel et al. 2008; Tonson et al.
2010).
Cardiomyopathy with left ventricular noncompaction
is a hallmark feature of BTHS (Barth et al. 1983; Spen-
cer et al. 2006). However, the majority of individuals
with BTHS have normal to low-normal systolic function
at rest (Spencer et al. 2006) that can unpredictably
decline and improve throughout childhood, adolescence
and young adulthood (Thompson et al. 2016). In this
study, we found impaired cardiac bioenergetic reserve
(i.e., PCr/ATP) in both children/adolescents and adults
with BTHS. This is in contrast to PCr/ATP data in one
infant with BTHS presented in the supplementary mate-
rial of a recent study (Wang et al. 2014). Also, PCr/ATP
was greater in adults versus children/adolescents in both
BTH and unaffected controls. The reason for these dif-
ferences remain unclear; one previous study found that
children rely more on oxidative metabolism versus cre-
atine kinase reaction than adults (Tonson et al. 2010),
however, these data were obtained from skeletal muscle.
The PCr energy system provides a reserve capacity for
cardiac and skeletal muscle to provide inorganic phos-
phate to adenosine diphosphate (ADP) in suprabasal
energy requiring states (Kemp et al. 2015; Neubauer
et al. 1997). Although many participants with BTHS
have normal or low normal systolic function, the ability
to increase myocardial contractility during high energy
requiring conditions (i.e., exercise) is impaired (Spencer
et al. 2011). Thus the reduced cardiac energetic reserve
in children/adolescents and young adults seen in this
study might explain the inability to increase myocardial
contractility during exercise and partially explain the
resultant exercise intolerance that is characteristic of
BTHS. PCr/ATP might be a useful prognostic factor in
BTHS, even in the absence of resting left ventricular
dysfunction, as PCr/ATP has been shown to be a better
predictor of cardiovascular mortality than ejection frac-
tion or heart failure classification in patients with non-
BTHS heart failure (Neubauer et al. 1997).
Exercise intolerance has been previously demonstrated
in both the BTHS-mouse model (i.e., TAZ knockdown)
(Powers et al. 2013) and in humans with BTHS (Cade
et al. 2016; Spencer et al. 2011); our current data confirm
these findings. Our earlier study found that exercise intol-
erance (i.e., diminished VO2peak) was mediated by both
cardiac and skeletal muscle impairments (Spencer et al.
2011). Specifically, we found that skeletal muscle oxygen
extraction measured by near-infrared spectroscopy (NIRS)
and systolic function was markedly blunted during exer-
cise in adolescents and young adults with BTHS com-
pared to unaffected, age-matched controls. Our data from
this study expand these findings and demonstrates that
impaired cardiac and skeletal muscle tissue bioenergetics
are associated with blunted whole-body oxygen consump-
tion during exercise. Although skeletal muscle mitochon-
drial function and whole-body oxygen consumption are
tightly associated and this relationship should be expected
(Larson-Meyer et al. 2000), this finding helps correlate
tissue-level bioenergetic impairments with functional out-
comes; a link not previously demonstrated in humans
with BTHS.
Our study found higher resting skeletal muscle [PCr]/
[Pi] in children/adolescents with BTHS and a tendency
for higher [PCr]/[Pi] in adults with BTHS when com-
pared with unaffected controls. Higher [PCr]/[Pi] is fre-
quently observed in muscles with large fraction of Type
2 (fast twitch) glycolytic fibers and the opposite is true
Table 3. Skeletal muscle bioenergetics during/postexercise.
Children Adults
Control (n = 16) BTHS (n = 14) P -value Control (n = 7) BTHS (n = 6) P -value
pH end 7.0  0.1 7.0  0.1 0.60 7.0  0.1 7.0  0.2 0.73
[ADP] end (lmol/L) 51.7  14.3 54.9  24.3 0.70 49.5  6.4 59.6  23.8 0.30
TPCr (sec) 31.4  7.3 71.5  21.3 <0.01 35.0  7.4 76.4  31.6 <0.01
Vi (mmol/L per sec) 0.3  0.1 0.2  0.1 <0.01 0.3  0.1 0.2  0.1 <0.01
Qmax-lin (mmol/L per sec) 1.1  0.3 0.5  0.1 <0.01 1.0  0.2 0.5  0.2 <0.01
Qmax-ADP (mmol/L per sec) 0.5  0.2 0.3  0.1 <0.01 0.5  0.2 0.3  0.1 <0.01
ATPox (mM/L per min) 20.6  5.7 12.7  4.5 <0.01 20.0  6.0 12.0  3.3 0.02
Values are means  SD.
ADP, adenosine diphosphate concentration; TPCr, Tau phosphocreatine; Vi, initial rate of PCr recovery; Qmax-lin, Q maximum linear equation;
Qmax-ADP, Q maximum ADP equation, ADP, adenosine diphosphate concentration, BTHS, Barth syndrome.
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in muscles with a large volume fraction of Type 1 (ox-
idative) fibers (Kushmerick et al. 1992; Takahashi et al.
1996). Although this study did not measure the fraction
of Type 1 versus Type 2 muscle fibers in participants,
previous data suggest that individuals with BTHS rely
on glycolytic metabolism to a greater extent than those
without BTHS, likely due to an impairment in fat oxi-
dation. Specifically, adolescents/young adults with BTHS
had a higher respiratory exchange ratio during exercise
(Spencer et al. 2011) and a greater glucose rate of dis-
posal during a hyperinsulinemic-euglycemic clamp pro-
cedure (Cade et al. 2013); both suggestive of higher
glycolytic dependence. If true, this higher glycolytic
capacity might be compensatory for an impaired capac-
ity to generate ATP via oxidative phosphorylation as
seen in this study.
We also found significantly higher resting skeletal
muscle phosphodiester (PDE) levels in children with
BTHS when compared to unaffected controls. PDE is an
intermediate of membrane phospholipid degradation,
may be related to membrane proliferation and remodel-
ing (Waters et al. 2003), and is elevated in other mito-
chondrial myopathies (Edwards et al. 1982; Matthews
et al. 1991). Elevated PDE has been associated with sar-
colemmal damage, muscle atrophy, and fiber loss (Tay-
lor et al. 1997), potentially resulting from excessive
reactive oxygen species production (Lanza and Nair
2010). Although not measured in this study, sarcolem-
mal disorganization has been previously shown in indu-
cible pluripotent stem cell derived BTHS-human
cardiomyocytes that was improved with linoleic acid
supplementation that resulted in a reduction in reactive
oxygen species production (Wang et al. 2014). Since
mitochondria contribute to the regulation of sarcomere
formation during cardiomyocyte maturation (Hom et al.
2011), PDE concentration via 31P-MRS might be a use-
ful biomarker for skeletal muscle sarcomere and mito-
chondrial membrane integrity assessed through potential
interventions.
There are some limitations of our study. Participants
with BTHS had lower fat-free mass (i.e., skeletal muscle)
which might contribute to worse PCr kinetics, however;
postexercise PCr recovery kinetics has been shown to be
independent of muscle mass (Minotti et al. 1990). Par-
ticipants with BTHS had higher [PCr]/[Pi] which could
potentially bias the calculation of Qmax-lin on the basis
of the resting [PCr] (Meyer 1988; Tonson et al. 2010),
but we found that Qmax-ADP (which is independent of
such bias (Layec et al. 2011)) was also significantly
reduced in participants with BTHS. PCr initial rate of
recovery (Vi) depends on ATP turnover during exercise
and can be affected by exercise intensity (i.e., work rate)
(Roussel et al. 2000). Although in this study work rate
was normalized via 1-repetition maximum testing, there
might have been interparticipant differences in exercise
work rate therefore affecting Vi. Although unaffected
controls reported a sedentary lifestyle, it is possible that
participants with BTHS were more inactive than their
peers and group differences in physical activity could
have affected the results. However, given the very large
group differences in mitochondrial energetics this was
not likely to be solely due to differences in physical
activity level. Also, several participants with BTHS were
taking cardiac supportive care therapy including
beta-blockers, ACE inhibitors and cardiac glycosides.
Beta-blocker therapy appears to improve mitochondrial
function through increase mitochondrial biogenesis and
protection from oxidative stress (Gomez et al. 2014;
Sgobbo et al. 2007; Yao et al. 2016). The effects of ACE
inhibitor therapy on mitochondrial function are not
clear: some studies demonstrating a protective effect
from physiologic insult (e.g., myocardial infarction)
(Hiona et al. 2011; Zoll et al. 2006) where other report
no significant effect on mitochondrial function, exercise
capacity, or protection from insult (Bahi et al. 2004;
Thaveau et al. 2010). Cardiac glycosides appear to have
a minimal effect on mitochondrial function in the
absence of toxicity (Liu et al. 2010). Taking these data
in sum, the effect, if any, of cardiac supportive therapy
on mitochondrial function would have likely been bene-
ficial and would have reduced the differences between
groups; making the comparison more conservative. Lack
of biological quantification of [PCr] and [ATP] concen-
trations is a limitation of this study. Muscle biopsy
could have provided these data (and other mitochon-
drial morphologic information), however, biopsy is an
invasive procedure which makes its use difficult in pedi-
atric populations and especially in those prone to bacte-
rial infections such as BTHS. Thus 31PMRS provides a
viable approach for this population and longitudinal
assessments.
Conclusion
In summary, we found altered cardiac and skeletal muscle
(calf) bioenergetics in children/adolescents and young
adults with BTHS that were associated with exercise intol-
erance. 31P-MRS is a useful technique that can quantify
mitochondrial impairments in BTHS and might be an
important biomarker or outcome measure in future inter-
vention studies.
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